ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > ˆÈ‘Oi•½¬9`22”N“xjŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > •½¬22”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹ÆŽ–‘O•]‰¿ˆÏˆõ–¼•ë

ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹ÆŽ–‘O•]‰¿ˆÏˆõ–¼•ë

i›FˆÏˆõ’·j

 
’rã@çŽõŽq “Á’è”ñ‰c—˜Šˆ“®–@l‚Õ‚ê‚¢‚·“Œ‹ž@‘ã•\
ƒZƒNƒ\ƒƒW[
ŽáŽÒ‚Ì«Š´õÇ‚ÉŠÖ˜A‚·‚é’mŽ¯‚â«s“®A«ˆÓŽ¯‚ÌŒ»óA’rãçŽõŽqAuŒöO‰q¶v‘æ‚V‚QŠª‚U†A444-450, 2008
ŒŸ¸‚ð‚æ‚è—LŒø‚É‚·‚邽‚ß‚Ì‘Š’k‘̧‚Ì®”õ‚ɂ‚¢‚ÄA’rãçŽõŽqAu•ÛŒ’ˆã—ÉȊwv‘æ‚T‚UŠª‚R†A224-229A2007
uŽv‚¢‚±‚Ý‚Ì«AƒŠƒXƒL[‚ȃZƒbƒNƒXvŠâ”g‘“X@i2011”Nj
 
¡‘º@’m–¾ “Þ—ÇŒ§—§ˆã‰È‘åŠwŒ’N­ôˆãŠwuÀ@‹³Žö
ŒöO‰q¶Šw
Toshio Ogawa, Manabu Akahane, Soichi Koike, Seizan Tanabe, Tatsuhiro Mizoguchi, Tomoaki Imamura
Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study. BMJ. 2011;342:c7106.
Imamura T, Kanagawa Y, Ebisawa M.
A survey of patients with self-reported severe food allergies in Japan. Pediatric Allergy and Immunology. 2008 May;19(3):270-274.
Imamura T, Ide H, Yasunaga H.
History of public health crises in Japan.@J Public Health Policy.@2007 Nov;28(2):221-237.
 
Šâ–{@ˆ¤‹g “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†ŠE‹³Žö
Š´õÇŠwEƒEƒCƒ‹ƒXŠw
1. Miyauchi, K., Curran, A.R., Long, Y., Kondo, N., Iwamoto, A., Engelman, D.M., and Matsuda, Z. The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein. Retrovirology 2010, 7:95. doi:10.1186/1742-4690-7-95. E- published, November 13, 2010.
2. Kondo, N., Miyauchi, K. Meng, F. Iwamoto, A. and Matsuda, Z.
Conformational changes of the HIV-1 envelope protein during membrane fusion were inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285:14681-14688, 2010.
3. 156. Koga, M., Kawana-Tachikawa, A., Heckerman, D., Odawara, T.,
Nakamura, H., Koibuchi, T., Fujii, T., Miura, T., and Iwamoto, A.
Transition of impact of HLA class I allele expression on HIV-1 plasma virus loads at a population level over time. Microbiol. Immunol. 54:196- 205, 2010.
‘q“c@‹B •xŽRŒ§‰q¶Œ¤‹†Š@Š’·
ƒEƒCƒ‹ƒXŠ´õÇ‚Ì•a—Šw
Kinomoto M, Yokoyama M, Sato H, Kojima A, Kurata T,Ikuta K, Sata T, Tokunaga K: Amino Acid 36 in the humana immunodeficiecy Virus Type 1 gp41 ectodomain controls fusogenic activity: Implications for the molecular mechanism of viral escape from a fusion inhibitor.
J Virol 79: 5996-6004, 2005
Maeda M., Sawa H., Tobiume M., Tokunaga K., Hasegawa H., Ichinohe T., Sata T., Moriyama M., Hall@W.W., Kurata T.and Takahashi H.:@Tristetraprotein inhibits HIV-I production by binding to genomic RNA. Microbes and Infection 8:2647-2656, 2006
Kinomoto M., Kanno T., Shimura M., Ishizaka Y., Kojima A., Kurata T., Sata T. and Tokunaga K.: All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Research 35:2955-2964, 2007
 
‘ŠŠy@—TŽq  
—Õ°Š´õÇŠw
“ˆ‹MŽqC{“¡O“ñC‹ß“¡^‹KŽqC‘qˆä‰ØŽqC‘ŠŠy—TŽqC¡ˆäŒõMFŒuŒõy‘f–Ɖu‘ª’è–@‚É‚æ‚éV‚µ‚¢HIVRŒ´R‘Ì“¯ŽžŒŸoŽŽ–òi‘æ4¢‘ãj‚ÌŒŸ“¢DŠ´õÇŠw‰ïŽ81F562-572C2007
’ËŒ´—DŒÈC‘ŠŠy—TŽqCŠì‘½P˜aC“ˆ‹MŽqC–î‰i—R—ŽqCŠO쳶C‘å‹à”ü˜aCˆî—tŒ›”VF‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´õ—«‚Ì”DPEoŽYEˆçŽ™Žx‰‡D“ú–{ƒGƒCƒYŠw‰ïŽ9F116-119C2007D
Mohri S, Yoshikawa K, Sagara H, Nakajima, HFA case of Penicillium marneffei infection in an AIDS patient  the first case in Japan . Jpn J
Med Mycol 41: 23-26, 2000.
 
ªŠÝ@¹Œ÷ ‚Ë‚¬‚µ“à‰Èf—Ê@Š’·
Š´õÇŠw
ƒGƒCƒYf—Âɂ¨‚¯‚éConsultation-Liaison Psychiatry@@ªŠÝ¹Œ÷A•Ûâ—²
¸_‰ÈŽ¡—Êw@1990@5;609-614C
wƒGƒCƒY‚ðf‚éx@@ªŠÝ¹Œ÷A”ªXŒ[A—kU“TA‹Êìd“¿‹¤’˜
’©“úV•·ŽÐi1987j
 
–ž‰®@—T–¾ ŒF–{‘åŠw ŒŒ‰t“à‰ÈEäPŒ´•a“à‰ÈEŠ´õ–Ɖuf—Õ”
Š´õÇŠwEŒŒ‰t“à‰ÈŠw
Ghosh, A.K., Chapsal, B.D., Weber, I.T., and Mitsuya, H.(2008) Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance. Acc. Chem. Res. 41: 78-86.
Maeda, K., Das, D., Yin, P., Tsuchiya, K., Ogata-Aoki, H., Nakata, H., Norman, R., Hackney, L., Takaoka, Y., and Mitsuya, H. (2008) Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: Insights to mechanism of allosteric inhibition. J. Mol. Biol. 381:956-974.
Aoki, M., Venzon, D.J., Koh, Y., Aoki-Ogata, H., Miyakawa, T., Yoshimura, K., Maeda, K., and Mitsuya, H. (2009) Non-cleavage site gag mutations in amprenavir-resistant HIV-1 predispose HIV-1 to rapid acquisition of amprenavir resistance but delays development of resistance to other protease inhibitors. J. Virol. 83:3059-3068.
 
‹{“c@ˆê—Y ƒGƒCƒY—\–hà’c—Ž–AŽYŒoV•·•ÒWˆÏˆõ
•ñ“¹
uƒs[ƒvƒ‹EƒEƒCƒYEƒGƒCƒYv‘¾˜YŽŸ˜YŽÐi1992”Nj
uƒGƒCƒYEƒfƒCƒYv•½–}ŽÐV‘i2000”Nj
u¢ŠE‚̓GƒCƒY‚Æ‚Ç‚¤“¬‚Á‚Ä‚«‚½‚Ì‚©vƒ|ƒbƒgo”Åi2003”Nj

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > ˆÈ‘Oi•½¬9`22”N“xjŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > •½¬22”N“xŒú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹ÆŽ–‘O•]‰¿ˆÏˆõ–¼•ë

ƒy[ƒW‚Ì擪‚Ö–ß‚é